AbbVie and Regenxbio have announced updates on the clinical development of ABBV-RGX-314, a potential...

PulseSight Therapeutics SAS has submitted a clinical trial authorization (CTA) to the Agence Nationa...

Sling Therapeutics has revealed positive topline efficacy and safety results from the Phase 2b/3 LID...

Samsara Vision has reported promising intermediate-term visual and safety outcomes for the SING IMT ...

Formycon AG, in partnership with Teva Pharmaceuticals International GmbH and Klinge Biopharma GmbH, ...

Bausch + Lomb has announced the acquisition of Whitecap Biosciences, LLC, a biotechnology company de...

Acelyrin has announced new data from its Phase 2 clinical trial of lonigutamab and revealed the desi...

Sight Sciences has announced the publication of a comprehensive 36-month analysis evaluating the lon...

Alkeus Pharmaceuticals has announced promising interim data from the TEASE-3 study, highlighting the...

Heidelberg Engineering has received FDA clearance for the new Epithelial Thickness Module on its Ant...